SEC Form 4 · accession 0001127602-18-008368
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Feb 23, 2018
Accepted (ET)
Feb 26, 2018 · 3:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2018 | A | 17,984 | $0.00 | A | 310,605 | D | |
| Common Stock | Feb 24, 2018 | F | 2,215 | $109.34 | D | 308,390 | D | |
| Common Stock | Feb 26, 2018 | F | 2,276 | $109.34 | D | 306,114 | D | |
| Common Stock | holding | — | — | — | 10,208 | I | 2016 GRAT | |
| Common Stock | holding | — | — | — | 29,954 | I | 2017 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 2,000 | I | Held By Self As Trustee For Zachary W. Foster | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $109.34 | Feb 23, 2018 | A | 81,181 | A | Feb 23, 2019 | Feb 23, 2023 | Common Stock | 81,181 | 81,181 | D |
Explanation of responses
- F1Consists of 17,984 unvested restricted stock units that vest equally over four (4) years beginning one (1) year from the date of issuance.
- F2Stock options vest as follows: 20,295 options vest one (1) year from the date of grant, 20,295 options vest two (2) years from the date of grant, 20,295 options vest (3) years from the date of grant, and 20,296 options vest four (4) years from the date of grant.